Tumor interferon signaling and suppressive myeloid cells are associated with CAR T-cell failure in large B-cell lymphoma
2021 · Blood · 278 citations
https://doi.org/10.1182/blood.2020007445
B
Biwei Cao
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
131
Papers
1.4K
Citations
16
h-index
24
i10-index
Biwei Cao is an academic researcher from Hubei University of Chinese Medicine. The author has contributed to research in topics: CAR-T cell therapy research & Lymphoma Diagnosis and Treatment & Immunotherapy and Immune Responses. The author has an h-index of 16, co-authored 112 publications.
ORCID: 0009-0000-4255-8369Papers by this author
worksPatterns and Predictors of Failure in Recurrent or Refractory Large B-Cell Lymphomas After Chimeric Antigen Receptor T-Cell Therapy
2021 · International Journal of Radiation Oncology*Biology*Physics · 49 citations
https://doi.org/10.1016/j.ijrobp.2021.06.038
Fucosylation of HLA-DRB1 regulates CD4+ T cell-mediated anti-melanoma immunity and enhances immunotherapy efficacy
2023 · Nature Cancer · 48 citations
https://doi.org/10.1038/s43018-022-00506-7
Characteristic of Clinical Studies on Baduanjin during 2000–2019: A Comprehensive Review
2020 · Evidence-based Complementary and Alternative Medicine · 31 citations
https://doi.org/10.1155/2020/4783915
PDXGEM: patient-derived tumor xenograft-based gene expression model for predicting clinical response to anticancer therapy in cancer patients
2020 · BMC Bioinformatics · 22 citations
https://doi.org/10.1186/s12859-020-03633-z
Factors associated with overall survival in breast cancer patients with leptomeningeal disease (LMD): a single institutional retrospective review
2024 · Breast Cancer Research · 11 citations
https://doi.org/10.1186/s13058-024-01789-7
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat